Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Immunology | Pulmonary/Respiratory Diseases | Hepatology (Liver, Pancreatic, Gall Bladder) | Infections and Infectious Diseases
Search Medical Condition
A listing of MAC Infection (Mycobacterium Avium Complex) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Mac Lung Infection
The MAC disease in AIDS is widely disseminated throughout the body and rarely involves the lung, while pulmonary MAC only involves the lungs. MAC pulmonary (lung) disease’ major susceptibility risk factors depend on which of the two types of disease are present. For nodular disease the risk factors are being Caucasian, female, average age. Mac Conditional Access; cancel. Turn on suggestions. Auto-suggest helps you quickly narrow down your search results by suggesting possible matches as you type. In particular, acceptance by Apple of an Order sent by Customer shall not be deemed an acceptance of any conflicting or additional terms and conditions. Apple specifically rejects any different or additional terms and conditions proposed by Customer, unless those terms and conditions are mutually agreed in writing in accordance with clause 16.4.
Found (5) clinical trials
Phase 2a Safety Tolerability Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
To evaluate the pharmacokinetics (PK) of SPR719 generated from the orally (po) administered SPR720 prodrug in a patient population with nontuberculous mycobacteria pulmonary disease (NTM-PD)
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
Clofazimine is an orphan antibiotic drug that is no longer available through pharmacies in the United States. It is approved for the treatment of Mycobacterium leprae (leprosy) infections. Clofazimine has been used for many years off-label against other Mycobacterium, including Mycobacteria avium complex (MAC) lung disease, an increasingly prevalent infection …
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Mycobacterium avium complex (MAC) are a subset of nontuberculous mycobacteria (NTM), environmental bacteria that can cause chronic, debilitating pulmonary disease, primarily affecting those over age 60. The goals of treatment are to improve symptoms, stop disease progression, and clear the infection. We propose to address a longstanding controversy in the …
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
Mac Disease
Scientific rationale and general description: Nontuberculous mycobacteria (NTM) represent all mycobacteria not belonging to the Mycobacterium tuberculosis complex. This group of mycobacteria was discovered recently and has demonstrated pulmonary pathogenicity. The presence of a NTM in a respiratory specimen is therefore not sufficient to confirm the diagnosis of a lung …
Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study
Condition For Maxima And Minima
This research is being done to better understand several important aspects of treatment of Mycobacterium avium complex (MAC) lung infections using an early bactericidal activity (EBA) study design. MAC is an environmental bacteria that can cause chronic lung infection. Early bactericidal activity is the amount of bacterial killing that occurs …
Mac Disease Stages